Allurion Technologies, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
Allurion Technologies, Inc. (ALUR) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $13.88 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2026-05-15
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2025-12-31 was $3.52M.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2025-06-30 was $0.00.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2025-03-31 was $10.37M.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2025 was $13.88M, a 6.35% decline from fiscal 2024.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2024 was $14.83M.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2022 was $834.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.52M derived: sum of 2 quarters · filed 2026-03-30 | $3.52M derived: sum of 3 quarters · filed 2026-03-30 | $13.88M 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $0.00 derived: sum of 2 quarters · filed 2025-11-17 | $10.37M 10-Q · filed 2025-11-17 | $10.37M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $10.37M 10-Q · filed 2025-08-19 | $10.37M derived: sum of 3 quarters · filed 2026-05-15 | $25.19M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | $10.37M 10-Q · filed 2026-05-15 | $10.37M derived: sum of 2 quarters · filed 2026-05-15 | $25.19M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $14.83M derived: sum of 2 quarters · filed 2026-03-30 | $14.83M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $14.83M 10-Q · filed 2025-11-17 | $14.83M 10-Q · filed 2025-11-17 | ||
| 2023-06-30 | $26.18M 10-Q · filed 2023-10-20 | |||
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $687.00K derived: sum of 2 quarters · filed 2025-08-28 | $834.00K derived: sum of 3 quarters · filed 2025-08-28 | $834.00K 10-K/A · filed 2025-08-28 |
| 2022-09-30 | $687.00K 10-Q · filed 2023-11-14 | $834.00K derived: sum of 2 quarters · filed 2023-11-14 | $834.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $147.00K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |